| 查看: 430 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题,病人别嘌醇0.1 bid 后尿酸仍在五百多,现在建议苯溴马隆口服,但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了,没有这方面的经验,请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
» 猜你喜欢
大家的面上项目去哪里查的啊?
已经有5人回复
国自然一点消息都没有,最后居然公布的时候有我的份!感恩
已经有9人回复
口腔颅颌面科学论文润色/翻译怎么收费?
已经有250人回复
视神经挤压损伤模型ONC小鼠实验相关
已经有2人回复
2024年度省自然基金中标的基金号什么时候有啊?
已经有12人回复
如果明天放榜,一般国合几点能查到?
已经有17人回复
稍安勿躁,这周估计不会出结果。
已经有2人回复
喜提第一个省自然面上,特来散金以表感谢
已经有182人回复













回复此楼